Thiamine-responsive megaloblastic anemia syndrome

20Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Thiamine-responsive megaloblastic anemia (TRMA) syndrome usually associated with diabetes mellitus, anemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein. The onset of disease is usually seen during infancy or at early childhood and most of the TRMA patients are originated from consanguineous families. In this case, we report a 5-month-old boy who had diagnosis of TRMA during evaluations for his anemia and thrombocytopenia. The diagnosis of TRMA should be kept in mind in differential diagnosis of megaloblastic anemia especially in the populations where the consanguinity is frequent. © 2010 The Japanese Society of Hematology.

Cite

CITATION STYLE

APA

Bay, A., Keskin, M., Hizli, S., Uygun, H., Dai, A., & Gumruk, F. (2010). Thiamine-responsive megaloblastic anemia syndrome. International Journal of Hematology, 92(3), 524–526. https://doi.org/10.1007/s12185-010-0681-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free